Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

746

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Asthma
Interventions
DRUG

Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID

MF/F 100/10 mcg via a metered dose inhaler (MDI) twice daily for 26 weeks

DRUG

Mometasone Furoate MDI (MF MDI)

MF 100 mcg via metered dose inhaler twice daily for 26 weeks

DRUG

Formoterol Fumarate 10 mcg

F via metered dose inhaler 10 mcg twice a day for 26 weeks

DRUG

Placebo

Placebo metered dose inhaler twice a day for 26 weeks

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Organon and Co

INDUSTRY

NCT00383552 - Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED) | Biotech Hunter | Biotech Hunter